We show here that TRAIL–CDK9i is capable of reducing the threshold for induction of mitochondrial apoptosis so potently that cancer cells which had been rendered resistant to chemo- or targeted therapy were still readily killed by TRAIL–CDK9i with high efficacy. Here, TNFSF10 is linked to cancer.